Pre-operative serum microRNA profiles differ between metabolic phenotypes and predict metabolic response to sleeve gastrectomy in severe obesity
- 1Center for Metabolic and Bariatric Surgery, Ohama Daiichi Hospital
Abstract
People with severe obesity show marked heterogeneity in cardiometabolic risk, classified as metabolically healthy (MHO) or unhealthy obesity (MUO). In this exploratory pilot study, we performed genome-wide serum microRNA (miRNA) profiling using Agilent SurePrint G3 microarrays (8 × 60 K; 2,549 probes) before and three months after sleeve gastrectomy (SG) in eight people with severe obesity (MHO n = 4; MUO n = 4) classified per Japanese national criteria. Despite comparable body mass index and visceral fat area, people with MUO had significantly higher HOMA-IR, fasting glucose, fasting insulin, HbA1c, and AST at baseline (all p = 0.029). Pre-operative miR-5100 expression correlated with baseline HOMA-IR (ρ = 0.805, p = 0.016) and predicted post-operative HOMA-IR reduction (ρ=−0.878, p = 0.004). Pre-operative miR-5585-3p predicted post-operative CRP reduction (ρ=−0.854, p = 0.007). Set analysis identified ten miRNAs, including miR-22-3p, detected in all MUO but no MHO participants. Welch’s t-test identified 23 miRNAs significantly altered post-operatively in MUO versus 8 in MHO. miR-8069 was consistently down-regulated after SG across all participants (Wilcoxon p = 0.016). Consistency across complementary analytical methods supports reliability despite the small sample. These preliminary findings suggest that pre-operative serum miRNA profiles may differ between MHO and MUO phenotypes and may predict metabolic responsiveness to bariatric surgery, and warrant validation in larger independent cohorts.
Related
- Baseline adipokine profiles have limited predictive value for weight-loss outcomes after laparoscopic sleeve gastrectomy: a prospective longitudinal cohort study
- Tirzepatide for Weight Recurrence After Metabolic and Bariatric Surgery: A Critical Review of Direct and Indirect Evidence with Emphasis on Sleeve Gastrectomy, Nutritional Safety, and Clinical Implications
- Changes in the CALLY Index After Sleeve Gastrectomy and Their Association with Weight Loss and Metabolic Parameters in Women
- microRNA-483 deficiency promotes loss of pancreatic β-cell identity and aberrant glucagon production under metabolic stress
- Intravenous Fat Emulsion Administration and Short-Term Lipid Profiles Under a Standardized Clinical Pathway After Gastrectomy: A Retrospective Observational Study
BibTeX
@article{inamine2026preoperative,
title = {{Pre-operative serum microRNA profiles differ between metabolic phenotypes and predict metabolic response to sleeve gastrectomy in severe obesity}},
author = {Susumu Inamine and Yasunori Uesato},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-69499-y},
url = {https://doi.org/10.1038/s41598-026-69499-y},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pre-operative serum microRNA profiles differ between metabolic phenotypes and predict metabolic response to sleeve gastrectomy in severe obesity
AU - Susumu Inamine
AU - Yasunori Uesato
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-69499-y
UR - https://doi.org/10.1038/s41598-026-69499-y
AB - People with severe obesity show marked heterogeneity in cardiometabolic risk, classified as metabolically healthy (MHO) or unhealthy obesity (MUO). In this exploratory pilot study, we performed genome-wide serum microRNA (miRNA) profiling using Agilent SurePrint G3 microarrays (8 × 60 K; 2,549 probes) before and three months after sleeve gastrectomy (SG) in eight people with severe obesity (MHO n = 4; MUO n = 4) classified per Japanese national criteria. Despite comparable body mass index and visceral fat area, people with MUO had significantly higher HOMA-IR, fasting glucose, fasting insulin, HbA1c, and AST at baseline (all p = 0.029). Pre-operative miR-5100 expression correlated with baseline HOMA-IR (ρ = 0.805, p = 0.016) and predicted post-operative HOMA-IR reduction (ρ=−0.878, p = 0.004). Pre-operative miR-5585-3p predicted post-operative CRP reduction (ρ=−0.854, p = 0.007). Set analysis identified ten miRNAs, including miR-22-3p, detected in all MUO but no MHO participants. Welch’s t-test identified 23 miRNAs significantly altered post-operatively in MUO versus 8 in MHO. miR-8069 was consistently down-regulated after SG across all participants (Wilcoxon p = 0.016). Consistency across complementary analytical methods supports reliability despite the small sample. These preliminary findings suggest that pre-operative serum miRNA profiles may differ between MHO and MUO phenotypes and may predict metabolic responsiveness to bariatric surgery, and warrant validation in larger independent cohorts.
SN - 2045-2322
ER -